A nurse is preparing to administer corticosteroids to a client with HELLP syndrome who is 32 weeks pregnant.
What is the rationale for this intervention?
A.
To reduce inflammation in the liver
B.
To accelerate fetal lung maturity
C.
To increase maternal blood pressure
D.
To prevent fetal growth restriction
E.
None
The correct answer and Explanation is :
The correct answer is:
B. To accelerate fetal lung maturity
Explanation:
HELLP syndrome is a severe form of preeclampsia characterized by Hemolysis, Elevated Liver enzymes, and Low Platelets. It poses significant risks to both the mother and the fetus, and management often involves delivery, especially if the condition is severe. However, if the fetus is not yet mature enough to be delivered safely, corticosteroids can be administered to help improve fetal outcomes.
Rationale for Administering Corticosteroids:
- Fetal Lung Maturity:
The primary reason for administering corticosteroids to a pregnant woman with HELLP syndrome is to enhance fetal lung maturity. Corticosteroids, such as betamethasone or dexamethasone, stimulate the production of surfactant in the fetal lungs. Surfactant is a substance that reduces surface tension in the alveoli (air sacs) of the lungs, preventing their collapse and enabling effective breathing after birth. Premature infants are at high risk of respiratory distress syndrome (RDS) due to insufficient surfactant production. By accelerating lung maturity, corticosteroids decrease the likelihood of RDS and improve the chances of a better respiratory outcome for the premature infant. - Inflammation and Liver Function:
While corticosteroids have anti-inflammatory effects, which could theoretically help reduce liver inflammation, the primary goal in the context of HELLP syndrome is to improve fetal outcomes rather than directly addressing liver inflammation. The management of liver function in HELLP syndrome typically involves supportive care and monitoring, rather than corticosteroid therapy. - Blood Pressure and Growth Restriction:
Corticosteroids do not directly increase maternal blood pressure, which is often a concern in preeclampsia and HELLP syndrome. They also do not specifically prevent fetal growth restriction, though improving overall fetal health can indirectly benefit fetal growth.
In summary, the administration of corticosteroids in this scenario is primarily aimed at accelerating fetal lung maturity to reduce the risk of complications associated with premature birth.